Unicycive Therapeutics, Inc.
Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications
Visit unicycive.comWebsite listed by the cited source.- Category
- Wikidata businesses
- Profile updated
- About this profile
- Public-sourced · Unclaimed
At a glance
Published details, with a source for each fact.
- Source description
Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications
- Source-listed website
unicycive.com — https://unicycive.com/
- Wikidata item
Wikidata Q139379676
- Source revision
2482115829, modified 2026-04-16T10:40:47Z
Data formats & record details
Download this profile and inspect its supporting evidence.
- Entity ID
- urn:readyscan:entity:unicycive-therapeutics-inc-q139379676
- Material fingerprint
- fnv1a64:90635ef07e045a9b
- Entity revision
- fnv1a64:988d7fbc22c4d11c
- Published
- 2026-07-29
- Modified
- 2026-07-29
- Source summary
- Unicycive Therapeutics, Inc. — Wikidata Q139379676; Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications; source revision 2482115829, modified 2026-04-16T10:40:47Z.